Skip to main content

Table 3 ETS2 expression associated with the clinicopathological parameters in GC

From: lncRNA DLEU2 promotes gastric cancer progression through ETS2 via targeting miR-30a-5p

Clinicopathological parameters n ETS2 Low (n%) ETS2 High (n%) P
Gender
 Male 55 11 (20.0) 44 (80.0) 0.800
 Female 20 6 (30.0) 14 (70.0)
Age (years)
 < 60 33 11 (33.3) 22 (66.7) 0.041*
 ≥ 60 42 5 (11.9) 37 (88.1)
Tumor diameter (cm)
 < 5 31 9 (29.0) 22 (71.0) 0.409
 ≥ 5 44 8 (18.2) 36 (81.8)
Pathological grading
 I–II 23 12 (52.2) 11 (47.8) 0.001**
 III–IV 52 5 (9.6) 47 (90.4)
TNM staging
 T1–T2 15 7 (46.7) 8 (53.3) 0.023*
 T3–T4 60 10 (16.7) 50 (83.3)
  1. *P < 0.05